Talcum Powder Cancer Claims in Scotland
For the better part of sixty years, talcum powder was one of the most trusted products in the British home. It was marketed for babies. It sat on bathroom shelves and dressing tables in virtually every household in Scotland, and millions of women used it daily as part of an ordinary hygiene routine, often for decades, precisely because it was presented as gentle, pure and safe.
That product is now at the centre of some of the largest consumer litigation ever brought in the United Kingdom. Thousands of claimants allege that talc-based powders sold between 1965 and 2023 were contaminated with asbestos, and that this contamination caused ovarian cancer, fallopian tube cancer, peritoneal cancer and mesothelioma in long-term users. In June 2026 the High Court in London made a Group Litigation Order gathering thousands of those claims into a single managed action. And, for the first time, a group of Scottish women have raised their own proceedings in the Scottish courts, meaning there is now a distinctly Scottish route through this litigation.
This essay explains what the claims allege, what the science and the regulators have said, how the litigation is structured on both sides of the border, who may be eligible to claim in Scotland, and the time limit rules that decide whether a claim can still be brought. One point should be made at the outset and kept in mind throughout: Johnson and Johnson, and Kenvue, the consumer health company spun off from it, deny all of the allegations. Their position is that their talc products did not contain asbestos and do not cause cancer. The courts will decide who is right. Nothing here should be read as a statement that the allegations are proven.
Why Talc and Asbestos Are Connected at All
Talc is a naturally occurring mineral, mined from the ground and milled into the soft powder familiar from the famous white bottle. Asbestos is also a naturally occurring mineral. The geological problem, and the root of the entire litigation, is that the two are often found together. Talc deposits and asbestos deposits form in similar rock, frequently side by side or interlaced, which means that talc extracted from the ground can carry asbestos fibres with it unless the deposit is clean or the contamination is removed.
Asbestos is one of the most extensively studied carcinogens in medical history. Its fibres, once inhaled or otherwise taken into the body, can lodge in tissue and cause cancers that emerge decades later. Mesothelioma, the cancer most strongly associated with asbestos, is well known in Scotland from its industrial history in the shipyards and building trades. The talc litigation alleges that the same fibres reached a very different population by a very different route: not laggers and joiners breathing asbestos dust at work, but women applying contaminated powder to their bodies over many years.
The claimants allege that internal company documents show the manufacturer knew of the contamination risk for decades, and that testing methods were chosen or applied in ways that failed to detect the fibres, while the product continued to be marketed as safe enough for babies. The company rejects that account entirely. It maintains that its talc was tested, that it did not contain asbestos, and that the scientific evidence does not establish that its products cause cancer. That factual dispute, about what was in the powder and what the company knew, is the central battleground of the litigation.
What the Science and the Regulators Have Said
The scientific record has moved considerably in recent years. In July 2024 the International Agency for Research on Cancer, the World Health Organization body responsible for classifying carcinogens, concluded its evaluation of talc and classified it as probably carcinogenic to humans. That classification sits one step below the certainty attached to asbestos itself, which has long been classified as carcinogenic to humans without qualification. The distinction matters legally: the claims do not depend only on talc in its pure form being harmful, but centrally on the allegation that the talc in question was contaminated with asbestos, an established carcinogen.
The commercial record has moved too. Talc-based baby powder was withdrawn from sale in the United States and Canada in 2020, and from the United Kingdom and the rest of the world in 2023, with the manufacturer citing commercial reasons and reformulating with cornstarch. In the United States, juries have returned substantial verdicts in talc cases, and the company has offered several billion dollars to resolve ovarian cancer claims, while continuing to deny liability. American verdicts and settlements prove nothing about the outcome of British proceedings, which will be decided under our own law and on the evidence before our own courts. But they explain why the UK litigation has gathered such scale so quickly.
The Group Litigation Order and the Scottish Action
Courts in the United Kingdom deal with mass claims through group mechanisms. In England and Wales the tool is the Group Litigation Order. When many people bring related claims raising common issues against the same defendant, the court gathers them under one order, manages the common questions together, and lets individual cases turn on their own facts within that framework. The Group Litigation Order in the Johnson and Johnson Baby Powder Litigation was made on the tenth of June 2026. By that point nearly two thousand claims had been issued, with thousands more claimants signed up and waiting to join, and the total value of the litigation estimated at more than a billion pounds.
Scotland has its own version of this machinery. Group proceedings in the Court of Session, introduced by the Civil Litigation (Expenses and Group Proceedings) (Scotland) Act 2018, allow a representative party to conduct proceedings on behalf of a group of claimants whose claims raise the same or similar issues. The talc action raised on behalf of Scottish women is the first contaminated talc case brought in the Scottish courts, and it means Scottish claimants are not simply an afterthought to English litigation. Scots law governs their claims, Scottish limitation rules apply, and Scottish damages law shapes what they can recover.
The legal foundations of the claims themselves are familiar ones. The Consumer Protection Act 1987 imposes strict liability on producers for defective products: where a product does not provide the safety persons generally are entitled to expect, the producer is liable for damage it causes without the claimant needing to prove negligence. Alongside that sits the common law of negligence, and the allegations of long corporate knowledge are directed at that case. In fatal cases, the Damages (Scotland) Act 2011 governs the claims of the family, which include compensation for grief and the loss of the deceased person's companionship, as well as the loss of financial support the deceased provided.
Who May Be Eligible to Claim
The pattern that runs through the claimant group is long, regular use of talc-based products followed, often many years later, by a diagnosis of one of four cancers: ovarian cancer, fallopian tube cancer, primary peritoneal cancer, or mesothelioma. The firms conducting the litigation generally look for around five years or more of regular use, though every case turns on its own facts, and the use can have occurred at any point in the long window between 1965 and 2023. It does not need to be recent. In most cases it will not be recent, because these are diseases of long latency.
Most claimants are women, reflecting both the marketing of the product and the cancers principally involved. But the group is not exclusively female. Mesothelioma and peritoneal cancer affect men as well, and a man diagnosed with either after long-term talc use may have a claim on the same basis.
The claimant group also, unavoidably, includes the families of people who have died. Ovarian cancer and mesothelioma are frequently fatal, and the solicitors conducting the English litigation have spoken publicly about the rate at which claimants are dying while the case proceeds. In Scotland, when a person dies from a disease caused by another's fault, the right to claim does not die with them. The executor can pursue the claim the deceased had, and the close family, a husband, wife, civil partner, children, parents and others, have their own claims under the Damages (Scotland) Act 2011. Families sometimes hesitate to enquire, feeling that a claim is somehow disrespectful to the person they have lost. It is worth saying gently that these family claims exist precisely because Parliament recognised that a wrongful death inflicts real losses on the living, and pursuing them is an entirely legitimate response to it.
One practical worry deserves to be put to rest, because it stops more people enquiring than almost anything else: nobody has receipts. No one kept proof of purchase for a bottle of baby powder bought in 1979, and no solicitor expects it. The evidence of use comes from the claimant's own account of which products they used, how often and over what period, supported where possible by the recollection of family members, alongside the medical records establishing the diagnosis. That is how these cases are built.
The Time Limit, and Why Old Exposure Does Not Mean an Old Claim
The rule that matters is in the Prescription and Limitation (Scotland) Act 1973. A personal injury claim in Scotland must generally be raised within three years. But the three years run not from the harmful exposure, and not from when the product was used, but from the date of knowledge: broadly, the date the person knew, or could reasonably have known, that they had a significant injury attributable to the thing now being blamed.
For a disease with a latency of decades, this distinction is everything. A woman who used talcum powder daily through the 1970s and 1980s and was diagnosed with ovarian cancer in 2024 is not forty-five years out of time. Her clock, in broad terms, started at diagnosis, or arguably even later, when the connection between talc and her cancer first became something she could reasonably have known about. Many people in exactly this position rule themselves out on instinct, assuming that anything so far in the past must be legally dead. The opposite is closer to the truth: the long gap between use and diagnosis is not a defect in these claims, it is their defining feature.
For families claiming after a death, the three-year period generally runs from the date of death. And where a deadline has arguably passed, Scottish courts retain a discretion under section 19A of the 1973 Act to allow a late claim where it is equitable to do so. None of this is a reason for delay, because limitation arguments are always better avoided than fought. But it is a reason never to assume, without advice, that a claim is out of time.
What Compensation Covers
Compensation in these claims, as in all Scottish personal injury claims, falls into two parts. The first is pain and suffering compensation, the award for the illness itself: the disease, the treatment, the fear, the loss of health and of the life the person would otherwise have led. For cancers of this severity the awards are substantial, commonly reaching six figures. The second part is the financial losses: earnings lost to illness, the cost of care provided by professionals or by family, treatment and travel costs, and everything else the disease has taken in money terms. In fatal cases, the family's awards for grief and lost companionship, and the lost financial support, are assessed under the 2011 Act.
Because this is group litigation, individual outcomes may ultimately be shaped by a negotiated settlement structure rather than by thousands of separate trials, as the American experience suggests is likely. What can be said with confidence is the simple, practical point: people who have registered claims participate in whatever outcome the litigation produces. People who never came forward do not.
The Bottom Line
The talcum powder litigation is about an ordinary product, used in ordinary bathrooms, by an enormous number of ordinary people, and an allegation that it carried one of the most dangerous substances known to medicine. Those allegations are denied and remain to be decided. But the legal machinery for resolving them is now fully in motion on both sides of the border: a Group Litigation Order in London made in June 2026, and the first Scottish group action raised in the Scottish courts.
For people in Scotland, the position can be stated simply. If you used talcum powder regularly for years, at any time between 1965 and 2023, and you have been diagnosed with ovarian cancer, fallopian tube cancer, peritoneal cancer or mesothelioma, you may be eligible to claim, and the fact that your talc use ended decades ago is no barrier, because the time limit runs from your date of knowledge, usually your diagnosis. If someone you loved died from one of these cancers after long-term talc use, your family may claim on their behalf. No receipts are needed, checking eligibility is free, and claims are conducted on a no win no fee basis, so there is nothing to pay unless the claim succeeds. The one genuinely urgent step is the first one: finding out, while the litigation is open and while the three-year clock allows, whether you are one of the people it exists for.